查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球人工视网膜市场 2023-2030
市场调查报告书
商品编码
1380452

全球人工视网膜市场 2023-2030

Global Artificial Retina Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 105 Pages | 商品交期: 2-3个工作天内

价格

预计全球人工视网膜市场在预测期（2023-2030年）将以8.1%的CAGR成长。人工视网膜市场的成长可归因于老年黄斑部病变和色素性视网膜炎等视网膜疾病的日益流行，以及对先进眼科治疗的需求不断增长。此外，人工视网膜设备的技术进步、医疗保健支出的增加以及患者对这些设备可用性的认识不断提高，预计将在未来几年推动市场成长。根据世界卫生组织 (WHO) 的数据，全球至少有 22 亿人有近距离视力或远端视力障碍。其中至少有 10 亿人的视力障碍本来可以预防或尚未解决。在全球范围内，视力障碍和失明的主要原因是屈光不正和白内障。

细分市场前景

全球人工视网膜市场按类型和最终用户进行细分。根据类型，市场分为视网膜前植入物、视网膜下植入物和神经外植入物。根据最终用户，市场细分为医院、诊所和研究机构。其中，视网膜前植入物由于其更好的安全特性，预计将占据相当大的市场份额。它可以透过比视网膜下植入物更小的切口进行植入和移除。这降低了併发症的风险，并且在必要时更容易更换植入物。

预计研究机构细分市场将在全球人工视网膜市场中占据相当大的份额

在最终用户中，研究机构细分市场预计将在全球人工视网膜市场中占据相当大的份额。此细分市场的成长归因于对更好和先进治疗的需求不断增加，因此公司和研究机构更加关注更好和改进设备的研究和试验。例如，2020年6月，由香港科技大学（科大）科学家领导的国际团队最近研发了全球首个3D人工眼，其性能优于现有的仿生眼，在某些情况下甚至超过了现有的仿生眼。为人形机器人带来视觉，为视力障碍患者带来新的希望。

区域展望

全球人工视网膜市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本） 、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于经济发展以及英国、德国等国家政府支持的不断增加，预计欧洲将在全球市场中占有显着份额。例如，2022 年 1 月，仿生眼植入物使英国盲人妇女能够检测到视觉讯号。这位来自达格纳姆的妇女患有地理萎缩症。这种情况是干性老年黄斑部病变 (AMD) 最常见的形式，影响着全世界数百万人，并可能导致失明。

北美地区预计全球人工视网膜市场CAGR显着成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。区域成长归因于强大的医疗基础设施和医疗产业研发的高支出。例如，2020 年1 月，匹兹堡大学医学中心(UPMC) 为美国第一位患者植入了新型无线视网膜设备，这是一项临床试验的一部分，旨在恢復晚期老年黄斑部病变(AMD) 患者的部分视力），一种导致永久性失明的疾病。除此之外，这些地区的主要老牌公司推出的产品正在稳步增加，进一步推动了该地区的医疗产业，进而推动了市场的成长。据美国国家医学图书馆称，Alpha AMS 视网膜下植入物改善了 6 名参与者中 5 名的视觉表现，并表现出长达 24 个月的持续功能。儘管植入手术仍然具有挑战性，但光学相干断层扫描 (OCT) 显微镜导引等新发展使手术技术得到了改进。

市场参与者展望

服务全球人工视网膜市场的主要公司包括： Altris, Inc.、Axorus、Bionic Vision Technologies、Intelligent Implants, Ltd.、Labtician Ophthalmics, Inc.、LambdaVision, Inc.、Medtronic、Nano Retina 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2023年4月，RetinAI和勃林格殷格翰联手利用人工智慧（AI）推动地理萎缩的辨识和治疗。这种合作关係有可能透过更精确地根据每个患者的具体情况量身定制治疗来彻底改变治疗方法。最终，这项合作旨在改变受视网膜疾病影响的个人的生活。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 在全球人工视网膜市场营运的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Aetna Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Bionic Vision Technologies
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Pixium Vision
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按产品类型分類的全球人工视网膜市场
    • 视网膜前植入物
    • 视网膜下植入物
    • 神经外植入物
  • 以最终用户分類的全球人工视网膜市场
    • 医院
    • 诊所
    • 研究机构

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Altris, Inc.
  • Axorus
  • Bionic Vision Technologies
  • Intelligent Implants, Ltd.
  • Labtician Ophthalmics, Inc.
  • LambdaVision, Inc.
  • Medtronic
  • Nano Retina
  • Nidek Co. Ltd.
  • Optobionics
  • Retina Implant AG
  • Vivani Medical Inc.
Product Code: OMR2027759

Title: Global Artificial Retina Market Size, Share & Trends Analysis Report by Type (Epiretinal Implants, Subretinal Implants, and Epineural implants), and by End User (Hospital, Clinics, and Research institutes)Forecast Period (2023-2030).

The global artificial retina market is anticipated to grow at a CAGR of 8.1% during the Forecast Period (2023-2030). The growth of the artificial retina market can be attributed to the increasing prevalence of retinal diseases such as age-related macular degeneration and retinitis pigmentosa, along with the growing demand for advanced ophthalmic treatments. Additionally, technological advancements in artificial retina devices, increasing healthcare expenditure, and rising awareness among patients about the availability of these devices are expected to drive market growth in the coming years. According to World Health Organization (WHO), globally, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion of these, vision impairment could have been prevented or is yet to be addressed. The leading causes of vision impairment and blindness at a global level are refractive errors and cataracts.

Segmental Outlook

The global artificial retina market is segmented on the type and end user. Based on the type, the market is sub-segmented into epiretinal Implants, subretinal Implants and epineural implants. And Based on the end user, the market is sub-segmented into hospital, clinics, and research institutes. Among the type, the Epiretinal Implants sub-segment is anticipated to hold a considerable share of the market, Owing to it better and safety features. It can be implanted and removed through a smaller incision than subretinal implants. This reduces the risk of complications and makes it easier to replace the implant if necessary.

The Research Institutes Sub-Segment is Anticipated to Hold a Considerable Share of the Global Artificial Retina Market

Among the end user, the research institutes sub-segment is expected to hold a considerable share of the global artificial retina market. The segmental growth is attributed to the increasing demand for better and advanced treatment, hence the companies and research institutes are focusing more on research and trails of better and improved devices. For instance, in June 2020, an international team led by scientists at the Hong Kong University of Science and Technology (HKUST) has recently developed the world's first 3D artificial eye with capabilities better than existing bionic eyes and in some cases, even exceed those of the human eyes, bringing vision to humanoid robots and new hope to patients with visual impairment.

Regional Outlook

The global artificial retina market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the economic development coupled with the increasing government support in countries such as UK, Germany, and others. For instance, in January 2022, Bionic eye implant enables blind UK woman to detect visual signals. The woman from Dagenham suffers from geographic atrophy. The condition is the most common form of dry age-related macular degeneration (AMD), which affects millions of people worldwide and can cause loss of sight.

The North America Region is Expected to Grow at a Significant CAGR in the Global Artificial Retina Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to strong healthcare infrastructure and high expenditure in R&D in medical industry. For instance, in January 2020, University of Pittsburgh Medical Center (UPMC) implanted the first patient in the US with a new wireless retinal device as part of a clinical trial aimed at restoring partial sight to patients with advanced age-related macular degeneration (AMD), a disease that leads to permanent blindness. Apart from this, the regions is witnessing a steady increase in product launches by key established companies, further advancing medical sector in the region, in turn propelling the market growth. According to National Library of Medicine, the Alpha AMS subretinal implant improved visual performance in 5 of 6 participants and has exhibited ongoing function for up to 24 months. Although implantation surgery remains challenging, new developments such as optical coherence tomography (OCT) microscope guidance added refinements to the surgical technique.

Market Players Outlook

The major companies serving the global artificial retina market include: Altris, Inc., Axorus, Bionic Vision Technologies, Intelligent Implants, Ltd., Labtician Ophthalmics, Inc., LambdaVision, Inc., Medtronic, Nano Retina, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2023, RetinAI and Boehringer Ingelheim have joined forces to advance the identification and treatment of geographic atrophy using artificial intelligence (AI). This partnership holds the potential to revolutionize treatments by tailoring them more precisely to each patient's specific condition. Ultimately, this collaboration aims to transform the lives of individuals affected by retinal diseases.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global artificial retina market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Aetna Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bionic Vision Technologies
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Pixium Vision
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Artificial retina Market by Product Type
    • 4.1.1. Epiretinal Implants
    • 4.1.2. Subretinal Implants
    • 4.1.3. Epineural Implants
  • 4.2. Global Artificial retina Market by End User
    • 4.2.1. Hospital
    • 4.2.2. Clinics
    • 4.2.3. Research Institutes

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Altris, Inc.
  • 6.2. Axorus
  • 6.3. Bionic Vision Technologies
  • 6.4. Intelligent Implants, Ltd.
  • 6.5. Labtician Ophthalmics, Inc.
  • 6.6. LambdaVision, Inc.
  • 6.7. Medtronic
  • 6.8. Nano Retina
  • 6.9. Nidek Co. Ltd.
  • 6.10. Optobionics
  • 6.11. Retina Implant AG
  • 6.12. Vivani Medical Inc.

LIST OF TABLES

  • 1. GLOBAL ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 2. GLOBAL EPIRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL SUBRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL EPINEURAL IMPLANTS IN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 6. GLOBAL ARTIFICIAL RETINA IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ARTIFICIAL RETINA IN CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ARTIFICIAL RETINA IN RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 13. EUROPEAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. EUROPEAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 15. EUROPEAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 16. ASIA- PACIFIC ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. ASIA- PACIFIC ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 18. ASIA- PACIFIC ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ARTIFICIAL RETINA MARKET SHARE BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL EPIRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL SUBRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL EPINEURAL IMPLANTS IN ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ARTIFICIAL RETINA MARKET SHARE BY END USER, 2022 VS 2030 (%)
  • 6. GLOBAL ARTIFICIAL RETINA IN HOSPITAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL ARTIFICIAL RETINA IN CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL ARTIFICIAL RETINA IN RESEARCH INSTITUTES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. US ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. CANADA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. UK ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. FRANCE ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. GERMANY ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. ITALY ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. SPAIN ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. REST OF EUROPE ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. INDIA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CHINA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. JAPAN ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SOUTH KOREA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)